Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

Background. Immunotherapy represents one of the fundamental treatments in the management of some types of cancer, especially malignant melanoma. Toxicity derived from increased immune system activity can manifest in multiple organs and systems. We present a case of hematological toxicity, manifested...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivares-Hernández, Alejandro, Figuero-Pérez, Luis, Amores Martín, María A., Bellido Hernández, Lorena, Mezquita, Laura, Vidal Tocino, María del Rosario, López Cadenas, Félix, Gómez-Caminero López, Felipe, Escala-Cornejo, Roberto A., Cruz Hernández, Juan Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895569/
https://www.ncbi.nlm.nih.gov/pubmed/33628551
http://dx.doi.org/10.1155/2021/6631859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895569/
https://www.ncbi.nlm.nih.gov/pubmed/33628551
http://dx.doi.org/10.1155/2021/6631859

Ejemplares similares